INTERCEPT Blood System for Plasma
Viruses
The INTERCEPT Blood System for plasma has been shown to inactivate a variety of viruses. Viruses shown to be inactivated are listed in Table 1.
Table 1: Inactivation Claims - Viruses
| Enveloped Viruses |
|
| HIV-1 (cell-associated)** |
>6.7 |
| HIV-1 (cell-free) |
>6.8 |
| HBV (strain MS-2) |
>4.5 |
| HCV (strain Hutchison) |
>4.5 |
| HTLV-I (Human T-cell Lymphotropic Virus)** |
≥4.5 |
| HTLV-II (Human T-cell Lymphotropic Virus)** |
>5.7 |
| WNV (West Nile Virus) |
≥6.8 |
| SARS-CoV (Human Corona Virus) |
≥5.5 |
| BVDV (Bovine Viral Diarrhea Virus, model virus for human HCV) |
≥6.0 |
| DHBV (Duck Hepatitis B Virus, model virus for human HBV) |
4.4 - 4.5 |
| Chikunguyna virus |
≥7.6 |
| Influenza A H5N1 virus (Avian Influenza) |
>5.7 |
| Non-Enveloped Viruses |
|
| BTV (Bluetongue Virus) |
5.1 |
| Human Adenovirus-5 |
≥6.9 |
| Parvo (Parvovirus B19) |
1.8 |
* “>” refers to inactivation below the limit of detection of the assay “≥” refers to inactivation at or below the limit of detection of the assay ** intracellular inoculum
Plasma Technical Data Sheet Page 3 of 7
|